Biomarkers of Risk of Parkinson Disease
Trial
N/A
Completed
Sept. 18, 2025
Deep Brain Stimulation and Parkinson's Disease
Trial
Early Phase 1
Completed
Sept. 18, 2025
Multimodal Artificial Intelligence Based Fall Risk Prediction in Parkinson's Disease
Trial
N/A
Completed
Sept. 18, 2025
Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)
Trial
N/A
Recruiting
Sept. 18, 2025
Technical Feasibility of Quantitative Susceptibility Mapping Radiomics for Predicting Deep Brain Stimulation Outcomes in Parkinson Disease.
Research
Neurosurgery
Sept. 18, 2025
Digital App for Speech & Health Monitoring
Trial
N/A
Recruiting
Sept. 17, 2025
Neocortical Microarchitecture of Executive Function
Trial
N/A
Recruiting
Sept. 16, 2025
Gut Microbiota Dysbiosis and Translocation During IBD and Parkinson
Trial
N/A
Completed
Sept. 15, 2025
Towards Noninvasive DBS of the Basal Ganglia in Parkinson's Disease Using TUS
Trial
N/A
Active, not recruiting
Sept. 14, 2025
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)
Trial
Phase 2
Completed
Sept. 14, 2025
Modulate Tremor Severity With Low-intensity Focused Ultrasound Stimulation Targeting the Deep Nucleus of Patients With Refractory Hand Tremor.
Trial
N/A
Recruiting
Sept. 14, 2025
A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease
Trial
Phase 1
Recruiting
Sept. 11, 2025
A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment
Trial
Phase 2
Completed
Sept. 11, 2025
Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease
Trial
Phase 1
Completed
Sept. 11, 2025
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
Trial
N/A
Recruiting
Sept. 11, 2025
Bilateral Putaminal Convection of Adeno-Associated Virus Vector Serotype 2 Glial Cell Line-Derived Neurotrophic Factor Gene Therapy in Parkinson's Disease May Provide Glial Cell Line-Derived Neurotrophic Factor Transgene Expression to Caudate Nucleus: Potential Role of Perivascular and Other Low Resistance Leakage Pathways.
Research
Neurosurgery
Sept. 11, 2025
Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease
Trial
Phase 1
Enrolling by invitation
Sept. 10, 2025
The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease
Trial
Phase 1
Recruiting
Sept. 10, 2025
Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
Trial
Phase 2
Recruiting
Sept. 9, 2025
The Effects of Scapulohumeral Rehabilitation on Scapula Kinematics and Upper Extremity Functionality in Individuals With Parkinson's Disease
Trial
N/A
Active, not recruiting
Sept. 9, 2025